KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Cash from Operations (2016 - 2025)

Thermo Fisher Scientific's Cash from Operations history spans 17 years, with the latest figure at 3457000000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Operations rose 5.08% year-over-year to 3457000000.0, compared with a TTM value of 7818000000.0 through Dec 2025, down 9.8%, and an annual FY2025 reading of 7818000000.0, down 9.8% over the prior year.
  • Cash from Operations for Q4 2025 was 3457000000.0 at Thermo Fisher Scientific, up from 2239000000.0 in the prior quarter.
  • The five-year high for Cash from Operations was 3723000000.0 in Q4 2023, with the low at 723000000.0 in Q1 2025.
  • Average Cash from Operations over 5 years is 2167850000.0, with a median of 2184000000.0 recorded in 2022.
  • Year-over-year, Cash from Operations skyrocketed 455.62% in 2021 and then crashed 66.89% in 2023.
  • Tracing TMO's Cash from Operations over 5 years: stood at 2457000000.0 in 2021, then surged by 41.92% to 3487000000.0 in 2022, then grew by 6.77% to 3723000000.0 in 2023, then dropped by 11.63% to 3290000000.0 in 2024, then grew by 5.08% to 3457000000.0 in 2025.
  • Per Business Quant, the three most recent readings for TMO's Cash from Operations are 3457000000.0 (Q4 2025), 2239000000.0 (Q3 2025), and 1399000000.0 (Q2 2025).